Clinical Trials
4 trialsNCT03935282 2026-04-15
AH-HA
Wake Forest University Health Sciences
Phase NA Completed
NCT05228470 2026-01-06
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
Phase 2 Completed
NCT01169259 2025-11-06
VITAL
Brigham and Women's Hospital
Phase 3 Active not recruiting
NCT02422745 2025-09-24
COSMOS
Brigham and Women's Hospital
Phase 4 Completed